| Members |
targetComponentId |
| nervelæsion, ikke nærmere specificeret |
Nerve injury (disorder) |
| Nerve sheath tumor, no International Classification of Diseases for Oncology subtype |
Benign nerve sheath tumor |
| torakal spinalnervestruktur |
Structure of peripheral nerve of thorax |
| neurologiske lidelser, ikke nærmere specificeret |
Disorder of nervous system (disorder) |
| Nervous system disorders NOS |
Disorder of nervous system (disorder) |
| Nervous system examination depth NOS |
Neurological observable |
| Nervous system examination depth NOS |
Depth of nervous system examination |
| Nervous system operations NOS |
Operation on nervous system |
| Nervous system operations NOS |
Operation on nervous system |
| Nesochen sandvicensis |
Branta sandvicensis (organism) |
| Nettle rash |
A raised, erythematous papule or cutaneous plaque, usually representing short-lived dermal edema. |
| NeuRobot |
Robot |
| Neuralgia |
Neuralgia |
| neurinomatose |
Melanotic schwannoma |
| Neurokutan melanose-sekvens |
Neurocutaneous melanosis |
| Neuroectodermal endocrine syndrome |
Woodhouse-Sakati syndrome is a multisystemic disorder with characteristics of hypogonadism, alopecia, diabetes mellitus, intellectual deficit and extrapyramidal signs with choreoathetoid movements and dystonia. The onset is usually in adolescence. Additional manifestations may include sensorineural deafness, flattened T waves on ECG, seizures, sensory polyneuropathy, dysarthria, various craniofacial abnormalities (high forehead, flat occiput, triangular face, prominent nasal root, hypertelorism, and down-slanting palpebral fissures), scoliosis, hyperreflexia, and camptodactyly. Associated with mutations in the DCAF17 gene (2q31.1), encoding a nucleolar protein of unknown function. The disease is transmitted in an autosomal recessive manner. |
| Neurofibramatosis 3 |
A rare form of neurofibromatosis characterised by the development of multiple schwannomas (nerve sheath tumours), without involvement of the vestibular nerves, and often associated with chronic pain. Dysaesthesia and paraesthesia may also be present. Common localisations include the spine, peripheral nerves, and the cranium. |
| neurofibrom |
Benign neurofibroma |
| Neurofibromatose, type 3 |
A rare form of neurofibromatosis characterised by the development of multiple schwannomas (nerve sheath tumours), without involvement of the vestibular nerves, and often associated with chronic pain. Dysaesthesia and paraesthesia may also be present. Common localisations include the spine, peripheral nerves, and the cranium. |
| Neurol. diag. proced. - NOS |
Procedure on nerve |
| Neurol. diag. proced. - NOS |
Procedure on nerve |
| Neuroleptic malignant syndrome |
Neuroleptic malignant syndrome |
| Neurologic myelopathy-retired |
Spinal cord disorder (disorder) |
| Neurological disorder caused by ingestible alcohol |
Neurological disorder caused by ethanol (disorder) |
| Neurological disorder monitoring NOS |
Neurological disorder monitoring (regime/therapy) |
| Monitorering af neurologisk lidelse, ikke nærmere specificeret |
Neurological disorder monitoring (regime/therapy) |
| Neurologisk monitorering, ikke nærmere specificeret |
Neurological monitoring regime |
| Neurological monitoring NOS |
Neurological monitoring regime |
| Neurological status not worse than preoperative baseline |
Neurological status is consistent with or improved from preoperative baseline (finding) |
| neurologisk screening/screening af særlig sans, ikke nærmere specificeret |
Neurological/special sense screening |
| Neurological/special sense screening NOS |
Neurological/special sense screening |
| neurologisk behandling |
Neurology service |
| Neurolysis - action |
Destruction - action |
| Neurolytiske teknikker |
Destructive procedure of nerve |
| Neuroma (excl. acoustic) |
Neuroma (disorder) |
| neurom (undtagen akustisk) |
Neuroma (morphologic abnormality) |
| neurom iht. kategori |
Neuroma (morphologic abnormality) |
| neurom, ingen IDC-O-undertype |
Neuroma (morphologic abnormality) |
| Neuromuskulær diagnostisk indgreb |
Neuromuscular procedure |
| Neuromuscular transmission drug |
Skeletal muscle relaxant (substance) |
| Neuromyositis-retired |
Polymyositis |
| neuropatisk impotens |
Erectile dysfunction due to neuropathy |
| Neuroplasty NOS |
Neuroplasty (procedure) |
| abnormt fund ved kontrastneurodiografi |
Computed tomography of nervous system with contrast abnormal (finding) |
| normalt fund ved kontrastneurodiografi |
CT of nervous system with contrast normal |
| Neuroses or other mental disorder NOS |
Mental disorder |
| Neurotic, personality and other nonpsychotic disorders |
Mental disorder |
| Neurovascular island sensory skin flap NEC |
Neurovascular island sensory skin flap |
| neutral adrenalin 0,05 % øjendråber |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
| neutral adrenalin 0,1 % øjendråber |
Adrenaline 1 mg/mL eye solution |
| neutral adrenalin 0,25 % øjendråber |
Adrenaline 2.5 mg/mL eye solution |
| neutral adrenalin 0,5 % øjendråber |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
| Neutron |
Neutron |
| Nevirapine 50mg/5mL suspension |
Product containing precisely nevirapine 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| atrofisk nævus |
Melanocytic nevus (disorder) |
| Ny partiel nethindeløsning med multiple defekter |
Partial detachment of retina with multiple breaks of retina (disorder) |
| New patient screening NOS |
New patient screening status |
| New patient screening NOS |
New patient screening |
| New patient screening administration NOS |
New patient screening |
| ny seksuel kontakt |
Sexual relations with a person with whom the subject has not previously had such relations within a time frame relevant to some current health issue |
| fysiologisk icterus hos nyfødt, ikke nærmere specificeret |
Newborn physiological jaundice |
| nicardipinhydrochlorid 60 mg kapsel med modificeret udløsning |
Nicardipine only product in oral dose form |
| Nicardipine hydrochloride 60mg prolonged-release oral capsule |
Nicardipine only product in oral dose form |
| nicardipin kapsel med modificeret udløsning |
Nicardipine only product in oral dose form |
| Nicotine 10mg inhalator refill pack |
Nicotine only product |
| Nicotine 10mg inhalator starter pack |
Nicotine only product |
| nicotininhalator 10 mg |
Nicotine only product |
| nicotinplaster 11 mg/24 timer |
Nicotine 458 microgram/hour prolonged-release transdermal patch |
| nicotinplaster 22 mg/dag |
Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| Nicotine dependence with current use |
Nicotine dependence |
| gratis udlevering af nicotinsubstitution |
Nicotine replacement therapy |
| Nicotine replacement therapy provided free |
Nicotine replacement therapy |
| Nicotine replacement therapy provided free |
Nicotine replacement therapy |
| Nicotine stomatitis |
Leukokeratosis nicotina palati |
| startpakning bestående af nicotinsyre 375 mg tablet med modificeret udløsning + nicotinsyre 500 mg tablet med modificeret udløsning + nicotinsyre 750 mg tablet med modificeret udløsning |
Nicotinic acid only product in oral dose form |
| Nicotinic acid 375mg prolonged-release oral tablet |
Nicotinic acid only product in oral dose form |
| nifedipin 90 mg tablet med modificeret udløsning |
Product containing only nifedipine in oral dose form (medicinal product form) |
| Nifedipine 90mg prolonged-release oral tablet |
Product containing only nifedipine in oral dose form (medicinal product form) |
| nimodipin 200 µg/ml infusionsvæske, opløsning, 50 ml hætteglas |
Product containing precisely nimodipine 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| abort nr. 9 |
Past pregnancy history of multiple induced termination of pregnancy |
| Brystvortesekretion, ikke nærmere specificeret |
Nipple discharge symptom |
| Nipple discharge NOS |
Nipple discharge symptom |
| nisoldipin 40 mg tablet med modificeret udløsning |
Nisoldipine only product in oral dose form |
| Nisoldipine 40mg prolonged-release oral tablet |
Nisoldipine only product in oral dose form |
| Nitroderivatives and aminoderivatives of benzene and its homologues |
Benzene derivative hydrocarbon |
| Nitroglycerin 2.5mg |
Glyceryl trinitrate 2.5 mg oral capsule |
| No FH: NOS |
No family history of |
| Intet bevægeudslag ved aktiv ekstension af ankel |
No active range of ankle plantar flexion (finding) |
| Intet bevægeudslag ved aktiv fleksion af ankel |
No active range of ankle dorsiflexion (finding) |
| No alcohol abuse |
No evidence of alcohol use disorder (situation) |
| No antenatal care NOS |
No antenatal care |
| No antenatal care NOS |
No antenatal care |
| Ingen diagnose på akse I |
Psychological finding |
| Ingen diagnose på akse II |
Psychological finding |
| Ingen diagnose på akse III |
Psychological finding |
| Ingen diagnose på akse IV |
Psychological finding |
| Ingen diagnose på akse V |
Psychological finding |
| No family history: NOS |
No family history of |
| No follow-up NOS |
No follow-up arranged |
| No follow-up NOS |
No follow-up arranged |
| ingen kendte allergier |
No known allergy (situation) |
FHIR